US Patent 7728148 Acyclic oximyl hepatitis C protease inhibitors
Patent 7728148 was granted and assigned to Enanta Pharmaceuticals on June, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+136 characters)
Article
Patent abstract
The present invention discloses compounds of formula I or pharmaceutically acceptable salts, esters, or prodrugs thereof:
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07728148 Acyclic oximyl hepatitis C protease inhibitors US Patent 7728148 Acyclic oximyl hepatitis C protease inhibitors
Infobox
Patent Number
0772814800
Patent Number
772814800
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077281480
Date of Patent
June 1, 2010
0Patent Application Number
117589010
Date Filed
June 6, 2007
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077281480
Date of Patent
June 1, 2010
0Patent Application Number
117589010
Date Filed
June 6, 2007
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07728148 Acyclic oximyl hepatitis C protease inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07728148
Date of patent
June 1, 2010
Patent application number
11758901
Date Filed
June 6, 2007
Patent primary examiner
Find more entities like US Patent 7728148 Acyclic oximyl hepatitis C protease inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.